[(DPEPhos)(bcp)Cu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst
May 21st, 2019
9K views
Detailed and general protocols are presented for the synthesis of [(DPEPhos)(bcp)Cu]PF6, a general copper-based photoredox catalyst, and for its use in synthetic chemistry for the direct arylation of C-H bonds in (hetero)arenes and radical cyclization of organic halides.
Overview
This article presents protocols for synthesizing a copper-based photoredox catalyst, [(DPEPhos)(bcp)Cu]PF 6, and its application in synthetic chemistry. The catalyst facilitates the direct arylation of C-H bonds and radical cyclization of organic halides.
Key Study Components
Area of Science
- Chemistry
- Photoredox Catalysis
- Organic Synthesis
Background
- Photoredox catalysis is an efficient method for promoting radical processes.
- It is user-friendly and sustainable, avoiding toxic reagents.
- Most existing catalysts are based on expensive metals like ruthenium and iridium.
- Developing cheaper alternatives using non-noble metals like copper is crucial.
Purpose of Study
- To synthesize a new copper-based photoredox catalyst.
- To demonstrate its application in synthetic chemistry.
- To provide protocols for its use in radical processes.
Methods Used
- Synthesis of [(DPEPhos)(bcp)Cu]PF 6 catalyst.
- Application in direct arylation of C-H bonds.
- Radical cyclization of organic halides.
- Utilization of visible light for catalyst activation.
Main Results
- The synthesized copper-based catalyst is effective in promoting radical reactions.
- It provides a cost-effective alternative to noble metal catalysts.
- Demonstrated successful applications in synthetic chemistry.
- Protocols are provided for reproducibility in research.
Conclusions
- The new copper-based photoredox catalyst offers a sustainable option for radical processes.
- It expands the toolbox for synthetic chemists.
- Future research can explore further applications and optimizations.
Frequently Asked Questions
What is photoredox catalysis?
Photoredox catalysis is a method that uses light-responsive catalysts to promote radical processes in organic synthesis.
Why is copper used as a catalyst?
Copper is a cheaper alternative to noble metals like ruthenium and iridium, making it more accessible for various applications.
What are the applications of the synthesized catalyst?
The catalyst can be used for direct arylation of C-H bonds and radical cyclization of organic halides.
How does the catalyst work?
The catalyst is activated by visible light, initiating a catalytic cycle that promotes radical reactions.
Are there any safety concerns with this method?
This method is designed to be user-friendly and avoids the use of toxic reagents commonly found in radical chemistry.
What protocols are provided in the study?
Detailed protocols for synthesizing the catalyst and its applications in synthetic chemistry are included.
Executive Industry Relevance
The development of [(DPEPhos)(bcp)Cu]PF6 as a copper-based photoredox catalyst addresses the need for cost-effective, scalable alternatives to noble metal catalysts in synthetic chemistry. Its broad substrate scope and compatibility with radical transformations enable efficient access to diverse small molecules and biologically relevant compounds. This capability supports early-stage medicinal chemistry and portfolio expansion by reducing reliance on expensive iridium and ruthenium systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rapid synthesis of structurally diverse small molecules for target interrogation.
- Facilitates access to analogs and natural product scaffolds for functional validation.
- Supports mechanistic de-risking by providing clean, reproducible transformations.
Screening & Assay Development
- Provides reliable routes to pure compounds for assay development and screening libraries.
- Ensures reproducibility and scalability in compound synthesis workflows.
- Delivers well-characterized outputs suitable for downstream biological evaluation.
Translational & Preclinical Research
- Enables synthesis of bioactive molecules and natural products for preclinical studies.
- Supports translational continuity by facilitating access to complex chemical matter.
- Reduces synthetic bottlenecks in advancing lead compounds toward in vivo validation.
Pipeline & Workflow Integration
[(DPEPhos)(bcp)Cu]PF6 integrates into the discovery-to-preclinical continuum by enabling efficient, scalable synthesis of diverse chemical entities.
- Discovery Biology: Accelerates hypothesis testing by providing rapid access to analogs and tool compounds.
- Screening: Delivers reproducible, high-purity compounds for robust assay deployment.
- Analytics: Supports quantitative NMR and spectroscopic characterization for confident structure confirmation.
- Translational Research: Facilitates synthesis of molecules relevant to disease models and biomarker studies.
- Enterprise Reuse: Offers a broadly applicable, cost-effective platform for ongoing medicinal chemistry campaigns.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in synthetic access to target molecules.
- Operational Value: Standardizes and simplifies photoredox workflows for routine use.
- Strategic Value: Reduces material costs and expands chemical space for portfolio growth.
- Portfolio Impact: Enables risk-adjusted prioritization by lowering synthetic barriers to lead advancement.
Implementation Considerations
- Requires expertise in inert-atmosphere and photoredox techniques.
- Needs access to photoreactors, NMR, and spectroscopic instrumentation.
- Demands strict oxygen exclusion for optimal yields and reproducibility.
- Adaptable to a range of organic halides and (hetero)arenes as supported by the protocol.
- Light safety and handling protocols must be enforced during photoreactor operation.
Biopharma FAQs
Why does null hypothesis testing matter for photoredox catalyst validation?
Null hypothesis testing ensures that observed reactivity and selectivity with [(DPEPhos)(bcp)Cu]PF6 are statistically significant and not due to uncontrolled variables. This underpins confidence in the catalyst's generality and suitability for target validation workflows.
How does independent variable isolation fit the photoredox screening pipeline?
Isolating variables such as light wavelength, substrate type, and atmosphere allows teams to attribute observed outcomes directly to the catalyst's performance. This supports robust optimization and reproducibility in early discovery pipelines.
What do quantitative NMR and spectroscopic measurements enable in catalyst evaluation?
Quantitative NMR and spectroscopic data confirm product identity and purity, enabling reliable comparison of reaction conditions and supporting data-driven decisions in compound progression.
Why are replication requirements critical for cross-functional chemistry teams?
Replication ensures that synthetic protocols using [(DPEPhos)(bcp)Cu]PF6 yield consistent results across different operators and labs, facilitating cross-team adoption and integration into broader R&D workflows.
What statistical analysis capabilities are required before implementing new photoredox protocols?
Teams must apply statistical analysis to yield, purity, and selectivity data to validate protocol robustness and identify optimal conditions, ensuring reliable scale-up and portfolio impact.
![Mizoroki-Heck Cross-coupling Reactions Catalyzed by Dichloro{bis[1,1',1''-(phosphinetriyl)tripiperidine]}palladium Under Mild Reaction Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F51444.jpg%3Fv%3D2026-08-25T08%253A15%253A26.000Z&w=384&q=75)
![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg%3Fv%3D2026-08-30T08%253A32%253A23.000Z&w=384&q=75)
